Tema Heart & Health ETF

HRTSNASDAQ · USD
38.48USD+0.01 (+0.03%)

Tema Heart & Health ETF (HRTS) Option Chain

Read more

Tracking the HRTS option chain helps you see every strike and expiry on Tema Heart & Health ETF in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of HRTS options activity at a glance. Use our scanner to monitor the HRTS option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For HRTS stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where HRTS options are being actively traded, and where they are not.

The Tema Heart & Health ETF (HRTS) seeks to invest in companies that potentially stand to benefit from further advances in biotechnology and healthcare, specifically companies involved in cardiology, metabolic diseases and weight loss therapies.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
11.92000.222.481.104.3036.00-6.42—0.200.000.2003888.08
24.43000.301.480.253.3037.00-3.82—0.750.000.750075.57
41.33001.050.480.502.5538.00-1.22—1.900.001.900058.67
59.58000.880.000.051.7039.00+1.38—1.900.521.380040.42
75.55001.050.00—1.0540.00+3.980.153.301.520.200024.45

As of Nov 5, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →

Stock Statistics

  • IndustryExchange Traded Fund
  • SectorFinancial
  • IV Rank44.84% Moderate
  • Market cap (M$)—
  • 52 weeks high-3.63%
  • 52 weeks low19.21%
  • Analyst recommendation—
  • Target price—
  • Dividend—
  • Payout ratio—
  • Earnings date—
  • P/E—
  • Future P/E—
  • EPS (ttm)—
  • EPS growth next 5 years—

As of Nov 5, 2026